Substitution of Cys209 for a serine residue resulted in decreased glycolysis and subsequent GBM tumour growth, indicating that GLUT1 palmitoylation by DHHC9 is involved in promoting GBM tumorigenesis through upregulating glycolytic processes (Zhang et al., 2021). The gene discussed is ZDHHC9; the disease is glioblastoma.